Skip to main content
Livermore
Livermore
ZHEN

Aviva PLC

SEC CIK
0001140022
Latest filing
Aug 13, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Aviva PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
223,593
Value
$111.1M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Aviva PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026223,593$111.1M0.2%+1,141+0.5%AddedHolders
Q1 2026222,452$99.3M0.2%+6,241+2.9%AddedHolders
Q4 2025216,211$98.0M0.2%+11,322+5.5%AddedHolders
Q3 2025204,889$80.2M0.1%+12,229+6.3%AddedHolders
Q2 2025192,660$85.8M0.2%+11,970+6.6%AddedHolders
Q1 2025180,690$87.6M0.2%+25,200+16.2%AddedHolders
Q4 2024155,490$62.6M0.2%+30,650+24.6%AddedHolders
Q3 2024124,840$58.1M0.2%+2,923+2.4%AddedHolders
Q2 2024121,917$57.1M0.2%+23,916+24.4%AddedHolders
Q1 202498,001$41.0M0.1%−28,982−22.8%ReducedHolders
Q4 2023126,983$51.7M0.2%+17,357+15.8%AddedHolders
Q3 2023109,626$38.1M0.2%+8,816+8.7%AddedHolders
Q2 2023100,810$35.5M0.1%−55,572−35.5%ReducedHolders
Q1 2023156,382$49.3M0.2%+4,121+2.7%AddedHolders
Q4 2022152,261$44.0M0.2%−18,744−11.0%ReducedHolders
Q3 2022171,005$49.5M0.3%−23,816−12.2%ReducedHolders
Q2 2022194,821$54.9M0.3%+47,073+31.9%AddedHolders
Q1 2022147,748$38.6M0.2%+54,224+58.0%AddedHolders
Q4 202193,524$20.5M0.1%−8,617−8.4%ReducedHolders
Q3 2021102,141$18.5M0.1%+6,025+6.3%AddedHolders
Q2 202196,116$19.4M0.1%+9,156+10.5%AddedHolders
Q1 202186,960$18.7M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.